Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and Zynga.
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Thursday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, McDonald's, Microsoft and Tesla.
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way…
Jon C. Ogg These three health care companies included are expected to report their earnings on Tuesday morning.
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge Technologies and Wynn Resorts.
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku and Wells Fargo.
Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of December.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The November 15 short interest data has been compared with the previous report, and short interest in most…
